Last updated on July 2019

Evaluation iNduction Consolidation and Maintenance Treatment With Isatuximab Carfilzomib LEnalidomide and Dexamethasone

Brief description of study

A Clinical Phase II, multicenter, Open-label study evaluating iNduction, consolidation and maintenance treatment with Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary diagnosed high-risk multiple myeloma paTients

Clinical Study Identifier: NCT03104842

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.